The compliance qualifications of phospholipids are complete
Time:2026-08-26Compliance qualification is the fundamental threshold for food ingredients and pharmaceutical excipients to enter formal industrial production and global sales. In the food and pharmaceutical industries with strict supervision systems, incomplete certification, unqualified standards and missing filing qualifications will directly restrict product application, market access and batch production. Natural soybean phospholipids stand out among numerous functional additives with complete and authoritative dual certification systems for food grade and pharmaceutical grade. Covering international safety certification, domestic standard filing, pharmaceutical pharmacopoeia compliance and food system quality certification, its comprehensive qualification system fully meets the standardized access requirements of food processing, health food, pharmaceutical preparations and other high-standard scenarios, providing solid compliance guarantee for industrial large-scale application.
In terms of food-grade compliance, phospholipids have obtained a full set of mainstream global food safety system certifications. As natural food-derived ingredients, phospholipids comply with GB 2760 national food additive safety standards, realizing standardized filing and safe usage in domestic food production. Meanwhile, they pass authoritative international system certifications including FSSC 22000 food safety management system and ISO 9001 quality management system, covering the whole process from raw material planting, purification and processing to finished product storage and transportation. In addition, phospholipids hold Kosher and Halal international religious food certifications, breaking regional market access barriers and adapting to diversified global food export standards. Different from ordinary additives with single qualification, phospholipids’ multi-dimensional food safety certifications ensure stable compliance performance in all food processing links and various regional market supervision environments.
In the field of pharmaceutical-grade application, phospholipids have reached the highest industry standard compliance level and complete pharmacopoeia certification qualifications. High-purity refined phospholipids fully comply with the quality specifications of major global pharmacopoeias, including Chinese Pharmacopoeia (ChP 2020), United States Pharmacopeia (USP), European Pharmacopoeia (EP) and Japanese Pharmacopoeia (JP), covering oral pharmaceutical excipients and injection-grade high-standard specifications. All pharmaceutical-grade phospholipid products complete official filing with the Center for Drug Evaluation (CDE), with qualified filing status and complete batch inspection records. Strictly produced in accordance with GMP pharmaceutical production specifications, the products pass professional testing indicators such as endotoxin detection, sterility test and hemolysis stimulation test, meeting the rigorous safety requirements of pharmaceutical preparation production.
Complete compliance qualifications bring strong batch stability and traceability advantages. All certified phospholipid products implement standardized production and full-process quality monitoring, with each batch equipped with complete COA quality inspection reports, raw material source records and production process parameter files. Every quality indicator including purity, moisture, impurity content and microbial indicators strictly complies with certified standard values, avoiding batch qualification fluctuations common in uncertified auxiliary materials. The perfect traceability system helps enterprises complete factory inspection, market random inspection and third-party audit efficiently, greatly reducing compliance risks in production and sales links.
In industrial market competition, full qualification certification is an important core competitiveness of phospholipids. Many functional additives only have single food-grade qualifications and cannot enter the pharmaceutical industry, while some industrial-grade materials lack food safety certification and have limited application scenarios. Phospholipids’ dual food and pharmaceutical full-certification system achieves cross-industry scenario coverage. It not only supports the standardized production of daily food and health products, but also meets the strict access standards of the pharmaceutical industry, helping downstream enterprises simplify qualification verification links, shorten product declaration cycles, and improve market access efficiency of finished products.
Moreover, the authoritative and complete certification system verifies the inherent safety of phospholipids from an official perspective. All qualification certifications are issued through standardized sampling, professional testing and institutional review, proving that phospholipids have no toxic and side effects, no residual risks and good biological compatibility. Whether used in long-term daily food addition or high-purity pharmaceutical preparation carrier applications, they can maintain stable safety performance. This official authoritative recognition further enhances consumer trust and brand credibility, bringing long-term brand value and market premium space for downstream finished products.
Phospholipids possess a complete and authoritative compliance qualification system, covering food safety system certification, international market access certification and global pharmacopoeia pharmaceutical-grade filing and certification. The dual full-qualification layout of food grade and pharmaceutical grade makes it a rare cross-industry high-compliance functional ingredient in the market. It not only ensures standardized, safe and traceable industrial production, but also helps downstream enterprises reduce compliance costs, expand application scenarios and enhance market competitiveness, fully adapting to the increasingly stringent global food and pharmaceutical industry supervision standards.

CN




